Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.

scientific article published on 5 August 2005

Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/THX.2005.043943
P932PMC publication ID1747202
P698PubMed publication ID16085729
P5875ResearchGate publication ID7673960

P50authorAne JohannessenQ56073351
P2093author name stringGulsvik A
Bakke PS
Omenaas ER
P2860cites workGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summaryQ29614692
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperQ29614960
Gender differences in airway behaviour over the human life spanQ30496384
Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up studyQ30790513
Postal survey on airborne occupational exposure and respiratory disorders in Norway: causes and consequences of non-responseQ33705194
Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart StudyQ34504296
The association between occupational factors and adverse health outcomes in chronic obstructive pulmonary diseaseQ35501556
An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stagesQ35536523
Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agentsQ36253383
Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological studyQ39549815
Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden StudiesQ44809323
The GOLD classification has advanced understanding of COPD.Q47950295
Population impact of different definitions of airway obstruction.Q51655883
Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease.Q51686318
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers.Q51696510
Nonresponse in a community cohort study: predictors and consequences for exposure-disease associations.Q51700792
The relation of body mass index to asthma, chronic bronchitis, and emphysema.Q51701187
Occupational airborne exposure and the incidence of respiratory symptoms and asthma.Q51702037
Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?Q51708631
Expiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in Norway.Q53145189
Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult populationQ58840363
Prognostic Value of Nutritional Status in Chronic Obstructive Pulmonary DiseaseQ61875242
Performance evaluation of contemporary spirometersQ68698424
Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: a Norwegian community studyQ72289086
Maximum likelihood estimation of the attributable fraction from logistic modelsQ72610226
Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 updateQ73711410
Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1Q79924377
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectchronic obstructive pulmonary diseaseQ199804
P304page(s)842-847
P577publication date2005-08-05
P1433published inThoraxQ7796158
P1476titleImplications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study
P478volume60

Reverse relations

cites work (P2860)
Q23915116A case-control study of airways obstruction among construction workers
Q35694483A comparative study of COPD burden between urban vs rural communities in northern Thailand
Q30619543A score to predict short-term risk of COPD exacerbations (SCOPEX).
Q36865717Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit
Q27012096Ageing and the epidemiology of multimorbidity
Q37783859An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease
Q89970843Association of Nonobstructive Chronic Bronchitis With Respiratory Health Outcomes in Adults
Q51541860Associations between obstructive lung disease and symptoms of obstructive sleep apnoea in a general population.
Q36837701COPD prevalence in a random population survey: a matter of definition.
Q23912728Case definitions for chronic obstructive pulmonary disease
Q33931328Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions
Q51606521Chronic obstructive pulmonary disease in patients with end-stage kidney disease on hemodialysis.
Q36225551Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?
Q35906564Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study
Q37336211Defining chronic obstructive pulmonary disease in older persons
Q36373826Do current OELs for silica protect from obstructive lung impairment? A critical review of epidemiological data
Q33897221Do symptoms predict COPD in smokers?
Q37792835Earlier diagnosis and earlier treatment of COPD in primary care.
Q36099476Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function
Q36568757Epidemiology of chronic obstructive pulmonary disease: health effects of air pollution.
Q23922840Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010
Q36225974Feasible and simple exclusion criteria for pulmonary reference populations
Q41449935Genetic Variants in the Hedgehog Interacting Protein Gene Are Associated with the FEV1/FVC Ratio in Southern Han Chinese Subjects with Chronic Obstructive Pulmonary Disease.
Q36926621Global burden of COPD: risk factors, prevalence, and future trends
Q38617511Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Q39798721Impact of bronchodilator use on the prevalence of COPD in population-based samples
Q57955658Impact of diagnostic criteria on the prevalence of COPD
Q45387569Impact of switching to new spirometric reference equations on severity staging of airflow obstruction in COPD: a crosssectional observational study in primary care.
Q34374230Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care.
Q49963482Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based cohort.
Q53249129Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm.
Q37242230Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients
Q89907103Is the Disease Burden from COPD in Norway Falling off? A Study of Time Trends in Three Different Data Sources
Q35861330Ischemic heart disease among subjects with and without chronic obstructive pulmonary disease--ECG-findings in a population-based cohort study.
Q51135760Long-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European community respiratory health survey.
Q41680089Meta-analysis approach to study the prevalence of chronic obstructive pulmonary disease among current, former and non-smokers.
Q47143734Occupational exposure to vapor, gas, dust, or fumes and chronic airflow limitation, COPD, and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot).
Q43664449Overweight and obesity may lead to under-diagnosis of airflow limitation: findings from the Copenhagen City Heart Study.
Q37300877Pragmatic research and outcomes in asthma and COPD
Q33627627Pre- and post-bronchodilator airway obstruction are associated with similar clinical characteristics but different prognosis - report from a population-based study.
Q35451346Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study
Q100473655Prediction of chronic heart failure and chronic obstructive pulmonary disease in a general population: the Tromsø study
Q28387926Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study
Q23910517Prevalence of airflow obstruction in U.S. adults aged 40-79 years: NHANES data 1988-1994 and 2007-2010
Q37103925Prevalence of airflow obstruction in nonsmoking older individuals using different spirometric criteria: the AGES Reykjavik Study
Q39801292Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey
Q44506625Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008.
Q33824058Proportional classifications of COPD phenotypes.
Q43429950Psychometric properties of the Hospital Anxiety and Depression Scale and The General Health Questionnaire-20 in COPD inpatients.
Q37412908Pulmonary complications after abdominal surgery in patients with mild-to-moderate chronic obstructive pulmonary disease
Q27968911Pulmonary function among Latino thoroughbred horse farmworkers
Q48758418Pulmonary rehabilitation reduces depression and enhances health-related quality of life in COPD patients--especially in patients with mild or moderate disease.
Q30496983Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey
Q39632785Reversibility of airway obstruction vs bronchodilatation: do we speak the same language?
Q58061937Significant Bronchodilator Responsiveness and “Reversibility” in a Population Sample
Q39024368Spirometer Replacement and Serial Lung Function Measurements in Population Studies: Results From the SAPALDIA Study
Q46227278Spirometry for detection of undiagnosed chronic obstructive pulmonary disease in primary care
Q21093297Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema
Q47099683The impact of different spirometric definitions on the prevalence of airway obstruction and their association with respiratory symptoms
Q97568401The sputum microbiome is distinct between COPD and health, independent of smoking history
Q42764411Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story
Q37253026What defines abnormal lung function in older adults with chronic obstructive pulmonary disease?
Q84148874[Complexity in chronic obstructive pulmonary disease. Individualized treatment, new approaches, phenotypes and comorbidities]

Search more.